BIO 2026: Indiana, biopharma investment and the Lilly effect
The US drive to onshore biopharmaceutical manufacturing has yielded billions of dollars of industry investment, raising the stakes for states…
The US drive to onshore biopharmaceutical manufacturing has yielded billions of dollars of industry investment, raising the stakes for states…